{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:55:04Z","timestamp":1793710504381,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["VGR 2019-00193"],"award-info":[{"award-number":["VGR 2019-00193"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["ALFGBG-965244"],"award-info":[{"award-number":["ALFGBG-965244"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["ALFGBG-965452"],"award-info":[{"award-number":["ALFGBG-965452"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antihypertensive treatment is equally beneficial for reducing cardiovascular risk in both men and women. Despite this, the drug treatment, prevalence and control of hypertension differ between men and women. Men and women respond differently, particularly with respect to the risk of adverse events, to many antihypertensive drugs. Certain antihypertensive drugs may also be especially beneficial in the setting of certain comorbidities \u2013 of both cardiovascular and extracardiac nature \u2013 which also differ between men and women. Furthermore, hypertension in pregnancy can pose a considerable therapeutic challenge for women and their physicians in primary care. In addition, data from population-based studies and from real-world data are inconsistent regarding whether men or women attain hypertension-related goals to a higher degree. In population-based studies, women with hypertension have higher rates of treatment and controlled blood pressure than men, whereas real-world, primary-care data instead show better blood pressure control in men. Men and women are also treated with different antihypertensive drugs: women use more thiazide diuretics and men use more angiotensin-enzyme inhibitors and calcium-channel blockers. This narrative review explores these sex-related differences with guidance from current literature. It also features original data from a large, Swedish primary-care register, which showed that blood pressure control was better in women than men until they reached their late sixties, after which the situation was reversed. This age-related decrease in blood pressure control in women was not, however, accompanied by a proportional increase in use of antihypertensive drugs and female sex was a significant predictor of less intensive antihypertensive treatment.<\/jats:p>","DOI":"10.1038\/s41371-023-00801-5","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T05:44:04Z","timestamp":1674107044000},"page":"662-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7771-7216","authenticated-orcid":false,"given":"Johan-Emil","family":"Bager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-7138","authenticated-orcid":false,"given":"Karin","family":"Manhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-8460","authenticated-orcid":false,"given":"Tobias","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hjerpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Bengtsson-Bostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mourtzinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"801_CR1","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"K Rahimi","year":"2021","unstructured":"Rahimi K, Bidel Z, Nazarzadeh M, Copland E, Canoy D, Ramakrishnan R, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625\u201336.","journal-title":"Lancet"},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1093\/eurheartj\/ehn427","volume":"29","author":"F Turnbull","year":"2008","unstructured":"Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29:2669\u201380.","journal-title":"Eur Heart J"},{"key":"801_CR3","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","volume":"388","author":"MH Forouzanfar","year":"2016","unstructured":"Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659\u2013724.","journal-title":"Lancet."},{"key":"801_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","volume":"96","author":"SS Franklin","year":"1997","unstructured":"Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. Circulation. 1997;96:308\u201315.","journal-title":"Circulation."},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11886-009-0080-2","volume":"12","author":"RW Persky","year":"2010","unstructured":"Persky RW, Turtzo LC, McCullough LD. Stroke in women: disparities and outcomes. Curr Cardiol Rep. 2010;12:6\u201313.","journal-title":"Curr Cardiol Rep"},{"key":"801_CR6","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/archinte.1989.00390120061012","volume":"149","author":"GR Gibson","year":"1989","unstructured":"Gibson GR. Enalapril-induced cough. Arch Intern Med. 1989;149:2701\u20133.","journal-title":"Arch Intern Med"},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/eurheartj\/ehi397","volume":"26","author":"N Jochmann","year":"2005","unstructured":"Jochmann N, Stangl K, Garbe E, Baumann G, Stangl V. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J. 2005;26:1585\u201395.","journal-title":"Eur Heart J"},{"key":"801_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40261-014-0191-4","volume":"34","author":"A Kajiwara","year":"2014","unstructured":"Kajiwara A, Saruwatari J, Kita A, Oniki K, Yamamura M, Murase M, et al. Younger females are at greater risk of vasodilation-related adverse symptoms caused by dihydropyridine calcium channel blockers: results of a study of 11,918 Japanese patients. Clin Drug Investig. 2014;34:431\u20135.","journal-title":"Clin Drug Investig"},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/jhh.2014.100","volume":"29","author":"C Ljungman","year":"2015","unstructured":"Ljungman C, Kahan T, Schi\u00f6ler L, Hjerpe P, Wettermark B, Bostr\u00f6m KB, et al. Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD). J Hum Hypertens. 2015;29:385\u201393.","journal-title":"J Hum Hypertens"},{"key":"801_CR10","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","volume":"320","author":"P Pouyanne","year":"2000","unstructured":"Pouyanne P, Haramburu F, Imbs JL, B\u00e9gaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ. 2000;320:1036.","journal-title":"BMJ."},{"key":"801_CR11","doi-asserted-by":"crossref","unstructured":"Bager J-E, Mourtzinis G, Andersson T, N\u00e5tman J, Rosengren A, Bj\u00f6rck S, et al. Trends in blood pressure, blood lipids, and smoking from 259 753 patients with hypertension in a Swedish primary care register: results from QregPV. Eur J Prev Cardiol. 2022;29:158\u201366.","DOI":"10.1093\/eurjpc\/zwab087"},{"key":"801_CR12","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020."},{"key":"801_CR13","unstructured":"RStudio Team. RStudio: integrated development for R. Boston, MA.: RStudio, PBC; 2021."},{"key":"801_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1089\/jwh.2008.0992","volume":"18","author":"C Ljungman","year":"2009","unstructured":"Ljungman C, Mortensen L, Kahan T, Manhem K. Treatment of mild to moderate hypertension by gender perspective: a systematic review. J Women\u2019s Health. 2009;18:1049\u201362.","journal-title":"J Women\u2019s Health"},{"key":"801_CR15","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269\u2013324.","DOI":"10.1161\/HYP.0000000000000066"},{"key":"801_CR16","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953\u20132041.","journal-title":"J Hypertens."},{"key":"801_CR17","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J."},{"key":"801_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","volume":"148","author":"R Kunz","year":"2008","unstructured":"Kunz R, Friedrich C, Wolbers M, Mann JF. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med. 2008;148:30\u201348.","journal-title":"Ann Intern Med"},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/ajh\/7.11.1012","volume":"7","author":"I Os","year":"1994","unstructured":"Os I, Bratland B, Dahl\u00f6f B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens. 1994;7:1012\u20135.","journal-title":"Am J Hypertens"},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40264-014-0239-7","volume":"38","author":"HM Abraham","year":"2015","unstructured":"Abraham HM, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015;38:33\u201354.","journal-title":"Drug Saf"},{"key":"801_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0333102413515348","volume":"34","author":"LJ Stovner","year":"2014","unstructured":"Stovner LJ, Linde M, Gravdahl GB, Tronvik E, Aamodt AH, Sand T, et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 2014;34:523\u201332.","journal-title":"Cephalalgia."},{"key":"801_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.289.1.65","volume":"289","author":"E Tronvik","year":"2003","unstructured":"Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003;289:65\u201369.","journal-title":"JAMA."},{"key":"801_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343\u20139.","journal-title":"Neurology."},{"key":"801_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/pds.554","volume":"9","author":"YS Kim","year":"2000","unstructured":"Kim YS, Park HS, Sunwoo S, Byeon JJ, Song YM, Seo HG, et al. Short-term safety and tolerability of antihypertensive agents in Korean patients: an observational study. Pharmacoepidemiol Drug Saf. 2000;9:603\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"801_CR25","doi-asserted-by":"publisher","first-page":"e006389","DOI":"10.1136\/bmjopen-2014-006389","volume":"5","author":"R Garner","year":"2015","unstructured":"Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud\u2019s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015;5:e006389.","journal-title":"BMJ Open"},{"key":"801_CR26","first-page":"Cd000467","volume":"12","author":"F Rirash","year":"2017","unstructured":"Rirash F, Tingey PC, Harding SE, Maxwell LJ, Tanjong Ghogomu E, Wells GA, et al. Calcium channel blockers for primary and secondary Raynaud\u2019s phenomenon. Cochrane Database Syst Rev. 2017;12:Cd000467.","journal-title":"Cochrane Database Syst Rev"},{"key":"801_CR27","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstr\u00f6m-Lundqvist C, C\u00edfkov\u00e1 R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: the Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:3165\u2013241.","journal-title":"Eur Heart J."},{"key":"801_CR28","doi-asserted-by":"publisher","unstructured":"Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev. 2011:CD005185. https:\/\/doi.org\/10.1002\/14651858.CD005185.pub2.","DOI":"10.1002\/14651858.CD005185.pub2"},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/HJH.0000000000001124","volume":"35","author":"T Bokrantz","year":"2017","unstructured":"Bokrantz T, Ljungman C, Kahan T, Bostrom KB, Hasselstrom J, Hjerpe P, et al. Thiazide diuretics and the risk of osteoporotic fractures in hypertensive patients. Results from the Swedish Primary Care Cardiovascular Database. J Hypertens. 2017;35:188\u201397.","journal-title":"J Hypertens"},{"key":"801_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/HJH.0000000000002245","volume":"38","author":"T Bokrantz","year":"2020","unstructured":"Bokrantz T, Schioler L, Bostrom KB, Kahan T, Mellstrom D, Ljungman C, et al. Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database. J Hypertens. 2020;38:167\u201375.","journal-title":"J Hypertens"},{"key":"801_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jamainternmed.2016.6821","volume":"177","author":"R Puttnam","year":"2017","unstructured":"Puttnam R, Davis BR, Pressel SL, Whelton PK, Cushman WC, Louis GT, et al. Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial. JAMA Intern Med. 2017;177:67\u201376.","journal-title":"JAMA Intern Med"},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.7326\/M13-2908","volume":"161","author":"A Qaseem","year":"2014","unstructured":"Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161:659\u201367.","journal-title":"Ann Intern Med"},{"key":"801_CR33","first-page":"e86","volume":"12","author":"V Romero","year":"2010","unstructured":"Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86\u201396.","journal-title":"Rev Urol"},{"key":"801_CR34","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1210\/jcem.84.6.5724","volume":"84","author":"P August","year":"1999","unstructured":"August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab. 1999;84:1862\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"801_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.ajkd.2013.02.365","volume":"62","author":"EM Rodenburg","year":"2013","unstructured":"Rodenburg EM, Hoorn EJ, Ruiter R, Lous JJ, Hofman A, Uitterlinden AG, et al. Thiazide-associated hyponatremia: a population-based study. Am J Kidney Dis. 2013;62:67\u201372.","journal-title":"Am J Kidney Dis"},{"key":"801_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.amjmed.2014.04.014","volume":"127","author":"JC van Blijderveen","year":"2014","unstructured":"van Blijderveen JC, Straus SM, Rodenburg EM, Zietse R, Stricker BH, Sturkenboom MC, et al. Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide. Am J Med. 2014;127:763\u201371.","journal-title":"Am J Med"},{"key":"801_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","volume":"270","author":"JD Neaton","year":"1993","unstructured":"Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of mild hypertension study: final results. JAMA. 1993;270:713\u201324.","journal-title":"JAMA."},{"key":"801_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/0003-4819-114-8-613","volume":"114","author":"S Wassertheil-Smoller","year":"1991","unstructured":"Wassertheil-Smoller S, Blaufox MD, Oberman A, Davis BR, Swencionis C, Knerr MO, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med. 1991;114:613\u201320.","journal-title":"Ann Intern Med"},{"key":"801_CR39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1751-7176.2011.00465.x","volume":"13","author":"J Handler","year":"2011","unstructured":"Handler J. Managing erectile dysfunction in hypertensive patients. J Clin Hypertens. 2011;13:450\u20134.","journal-title":"J Clin Hypertens"},{"key":"801_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1681\/ASN.2014030293","volume":"26","author":"A Blanchard","year":"2015","unstructured":"Blanchard A, Vargas-Poussou R, Vallet M, Caumont-Prim A, Allard J, Desport E, et al. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome. J Am Soc Nephrol. 2015;26:468\u201375.","journal-title":"J Am Soc Nephrol"},{"key":"801_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-8278(03)00188-0","volume":"39","author":"J Santos","year":"2003","unstructured":"Santos J, Planas R, Pardo A, Dur\u00e1ndez R, Cabr\u00e9 E, Morillas RM, et al. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. J Hepatol. 2003;39:187\u201392.","journal-title":"J Hepatol"},{"key":"801_CR42","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386:2059\u201368.","journal-title":"Lancet."},{"key":"801_CR43","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110:364\u201379.","journal-title":"Fertil Steril"},{"key":"801_CR44","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1210\/jc.2018-00241","volume":"103","author":"KA Martin","year":"2018","unstructured":"Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1233\u201357.","journal-title":"J Clin Endocrinol Metab"},{"key":"801_CR45","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1210\/jc.2009-0345","volume":"94","author":"WC Hembree","year":"2009","unstructured":"Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94:3132\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"801_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","volume":"131","author":"RP Ghose","year":"1999","unstructured":"Ghose RP, Hall PM, Bravo EL. Medical management of aldosterone-producing adenomas. Ann Intern Med. 1999;131:105\u20138.","journal-title":"Ann Intern Med"},{"key":"801_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.14740\/jocmr2851w","volume":"9","author":"R De Vecchis","year":"2017","unstructured":"De Vecchis R, Cantatrione C, Mazzei D, Barone A, Maurea N. The impact exerted on clinical outcomes of patients with chronic heart failure by aldosterone receptor antagonists: a meta-analysis of randomized controlled trials. J Clin Med Res. 2017;9:130\u201342.","journal-title":"J Clin Med Res"},{"key":"801_CR48","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/EJE-14-0444","volume":"172","author":"A Riester","year":"2015","unstructured":"Riester A, Reincke M. Progress in primary aldosteronism: mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol. 2015;172:R23\u201330.","journal-title":"Eur J Endocrinol"},{"key":"801_CR49","first-page":"1","volume":"2020","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;2020:1\u2013125.","journal-title":"Eur Heart J"},{"key":"801_CR50","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289\u2013367.","journal-title":"Eur Heart J."},{"key":"801_CR51","first-page":"Cd002003","volume":"1","author":"CS Wiysonge","year":"2017","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017;1:Cd002003.","journal-title":"Cochrane Database Syst Rev"},{"key":"801_CR52","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","volume":"78","author":"SD Silberstein","year":"2012","unstructured":"Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337\u201345.","journal-title":"Neurology."},{"key":"801_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jama.288.3.351","volume":"288","author":"DT Ko","year":"2002","unstructured":"Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. \u03b2-Blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351\u20137.","journal-title":"JAMA."},{"key":"801_CR54","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","volume":"283","author":"TA Officers","year":"2000","unstructured":"Officers TA, Group CftACR. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2000;283:1967\u201375.","journal-title":"JAMA"},{"key":"801_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","volume":"5","author":"BH van den Born","year":"2019","unstructured":"van den Born BH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5:37\u201346.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"801_CR56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/bja\/aeh083","volume":"92","author":"P Tauzin-Fin","year":"2004","unstructured":"Tauzin-Fin P, Sesay M, Gosse P, Ballanger P. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. Br J Anaesth. 2004;92:512\u20137.","journal-title":"Br J Anaesth"},{"key":"801_CR57","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/JU.0000000000002183","volume":"206","author":"LB Lerner","year":"2021","unstructured":"Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management. J Urol. 2021;206:806\u201317.","journal-title":"J Urol"},{"key":"801_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40256-021-00510-9","volume":"22","author":"U Ojha","year":"2022","unstructured":"Ojha U, Ruddaraju S, Sabapathy N, Ravindran V, Worapongsatitaya P, Haq J, et al. Current and emerging classes of pharmacological agents for the management of hypertension. Am J Cardiovasc Drugs. 2022;22:271\u201385.","journal-title":"Am J Cardiovasc Drugs"},{"key":"801_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","volume":"29","author":"RH Grimm Jr","year":"1997","unstructured":"Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension. 1997;29:8\u201314.","journal-title":"Hypertension."},{"key":"801_CR60","doi-asserted-by":"crossref","unstructured":"Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022;386:1781\u201392.","DOI":"10.1056\/NEJMoa2201295"},{"key":"801_CR61","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"B Zhou","year":"2021","unstructured":"Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet."},{"key":"801_CR62","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/HJH.0000000000000502","volume":"33","author":"V Barrios","year":"2015","unstructured":"Barrios V, Escobar C, Alonso-Moreno FJ, Prieto MA, Pallares V, Rodr\u00edguez-Roca G, et al. Evolution of clinical profile, treatment and blood pressure control in treated hypertensive patients according to the sex from 2002 to 2010 in Spain. J Hypertens. 2015;33:1098\u2013107.","journal-title":"J Hypertens."},{"key":"801_CR63","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/HJR.0b013e3282f37a45","volume":"15","author":"G Journath","year":"2008","unstructured":"Journath G, Hell\u00e9nius ML, Petersson U, Theobald H, Nilsson PM. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden. Eur J Cardiovasc Prev Rehabil. 2008;15:258\u201362.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"801_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/02813432.2021.2004841","volume":"39","author":"G Mourtzinis","year":"2021","unstructured":"Mourtzinis G, Manhem K, Kahan T, Schioler L, Isufi J, Ljungman C, et al. Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database. Scand J Prim Health Care. 2021;39:519\u201326.","journal-title":"Scand J Prim Health Care"},{"key":"801_CR65","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jash.2014.08.015","volume":"8","author":"C Ljungman","year":"2014","unstructured":"Ljungman C, Kahan T, Schi\u00f6ler L, Hjerpe P, Hasselstr\u00f6m J, Wettermark B, et al. Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD). J Am Soc Hypertens. 2014;8:882\u201390.","journal-title":"J Am Soc Hypertens"},{"key":"801_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/jch.13149","volume":"20","author":"F Wallentin","year":"2018","unstructured":"Wallentin F, Wettermark B, Kahan T. Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity. J Clin Hypertens. 2018;20:106\u201314.","journal-title":"J Clin Hypertens"},{"key":"801_CR67","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/jhh.2009.109","volume":"24","author":"MC Wong","year":"2010","unstructured":"Wong MC, Jiang JY, Griffiths SM. Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study. J Hum Hypertens. 2010;24:669\u201377.","journal-title":"J Hum Hypertens"},{"key":"801_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-016-0440-0","volume":"17","author":"AE Thompson","year":"2016","unstructured":"Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38.","journal-title":"BMC Fam Pract"},{"key":"801_CR69","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/fampra\/cmt033","volume":"30","author":"P W\u00e4ndell","year":"2013","unstructured":"W\u00e4ndell P, Carlsson AC, Wettermark B, Lord G, Cars T, Ljunggren G. Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011. Fam Pract. 2013;30:506\u201313.","journal-title":"Fam Pract"},{"key":"801_CR70","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/HYPERTENSIONAHA.112.201780","volume":"60","author":"S Cheng","year":"2012","unstructured":"Cheng S, Xanthakis V, Sullivan LM, Vasan RS. Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension. 2012;60:1393\u20139.","journal-title":"Hypertension."},{"key":"801_CR71","first-page":"204748732090869","volume":"0","author":"K Kotseva","year":"2020","unstructured":"Kotseva K, De Backer G, De Bacquer D, Ryd\u00e9n L, Hoes A, Grobbee D, et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur J Prev Cardiol. 2020;0:2047487320908698.","journal-title":"Eur J Prev Cardiol"},{"key":"801_CR72","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1097\/HJH.0000000000001429","volume":"35","author":"C Holmquist","year":"2017","unstructured":"Holmquist C, Hasselstr\u00f6m J, Bengtsson Bostr\u00f6m K, Manhem K, Wettermark B, Hjerpe P, et al. Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database. J Hypertens. 2017;35:2102\u20138.","journal-title":"J Hypertens"},{"key":"801_CR73","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s002280050553","volume":"54","author":"S Wallenius","year":"1998","unstructured":"Wallenius S, Kumpusalo E, P\u00e4rn\u00e4nen H, Takala J. Drug treatment for hypertension in Finnish primary health care. Eur J Clin Pharmacol. 1998;54:793\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"801_CR74","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887\u201398.","journal-title":"N Engl J Med"},{"key":"801_CR75","unstructured":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet. 2021;398:1053\u201364."},{"key":"801_CR76","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1741826710389369","volume":"18","author":"F Turnbull","year":"2011","unstructured":"Turnbull F, Arima H, Heeley E, Cass A, Chalmers J, Morgan C, et al. Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study. Eur J Cardiovasc Prev Rehabil. 2011;18:498\u2013503.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"801_CR77","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227\u2013337.","journal-title":"Eur Heart J."}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-023-00801-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-023-00801-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-023-00801-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T04:04:50Z","timestamp":1691121890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-023-00801-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":77,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1038\/s41371-023-00801-5","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}